Background illustration for clinical trials search

Paid Clinical Trials Renton

Discover 1,461 paid clinical trials in Renton, Washington. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.

Filter
2

Acalabrutinib in Combination With Venetoclax for the Treatment of Refractory or Recurrent Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma, The AVENUE-2 Trial

for
Recurrent Chronic Lymphocytic Leukemia,
Location: Seattle WA
Sponsor: Fred Hutchinson Cancer Center

Sex: All

Age: 18+

Code: NCT04941716

Phase 2, Recruiting

A Dose-Escalation and Expansion Study of Tacabrutideg (BGB-16673) in Participants With B-Cell Malignancies

for
B-cell Malignancy, Marginal Zone Lymphoma, Follicular Lymphoma,
Location: Seattle WA, Vancouver, Calgary, Edmonton, Palo Alto CA,
Sponsor: BeOne Medicines

Sex: All

Age: 18+

Code: NCT05006716

Phase 1, Phase 2, Recruiting

Graft Versus Host Disease-Reduction Strategies for Donor Blood Stem Cell Transplant Patients With Acute Leukemia or Myelodysplastic Syndrome (MDS)

for
Acute Leukemia, Acute Lymphoblastic Leukemia,
Location: Seattle WA, Pittsburgh PA, Tampa FL
Sponsor: Fred Hutchinson Cancer Center

Sex: All

Age: 1 - 60

Code: NCT03970096

Phase 2, Recruiting

ADG126 in Combination With Pembrolizumab in Patients With Advanced/Metastatic Solid Tumors

for
Advanced/Metastatic Solid Tumors
Location: Seattle WA, Duarte CA, Irvine CA, Scottsdale AZ,
Sponsor: Adagene Inc

Sex: All

Age: 18+

Code: NCT05405595

Phase 1, Phase 2, Recruiting

Establishing a ctDNA Biomarker to Improve Organ Preserving Strategies in Patients With Rectal Cancer

for
Rectal Adenocarcinoma, Stage II Rectal Cancer AJCC v8,
Location: Seattle WA, Portland OR
Sponsor: OHSU Knight Cancer Institute

Sex: All

Age: 18+

Code: NCT05081024

Recruiting

Interested in new trials?

Get alerts for new trials in your area by subscribing now

Subscriber Image

ACTengine® IMA203/IMA203CD8 as Monotherapy or in Combination With Nivolumab in Recurrent and/or Refractory Solid Tumors

for
Refractory Cancer, Recurrent Cancer, Solid Tumor, Adult, Cancer
Location: Seattle WA, Stanford CA, Aurora CO, Chicago IL,
Sponsor: Immatics US, Inc.

Sex: All

Age: 18+

Code: NCT03686124

Phase 1, Phase 2, Recruiting

Specialty Compared to Oncology Delivered Palliative Care for Patients With Acute Myeloid Leukemia

for
Relapsed Adult AML, Primary Refractory Acute Myeloid Leukemia,
Location: Seattle WA, Portland OR, Stanford CA, Denver CO,
Sponsor: Massachusetts General Hospital

Sex: All

Age: 18 - 70+

Code: NCT05237258

Recruiting

A Study of BH-30236 in Relapsed/ Refractory Acute Myelogenous Leukemia and Higher Risk Myelodysplastic Syndrome

for
Leukemia, Leukemia, Myeloid, Leukemia, Myeloid, Acute,
Location: Seattle WA, Palo Alto CA, Los Angeles CA, Duarte CA,
Sponsor: BlossomHill Therapeutics

Sex: All

Age: 18+

Code: NCT06501196

Phase 1, Recruiting

A Study of NX-1607 in Adults With Advanced Malignancies

for
Ovarian Cancer, Epithelial, Gastric Cancer,
Location: Seattle WA, San Francisco CA, Los Angeles CA, Aurora CO,
Sponsor: Nurix Therapeutics, Inc.

Sex: All

Age: 18+

Code: NCT05107674

Phase 1, Recruiting

Concurrent WOKVAC Vaccination, Chemotherapy, and HER2-Targeted Monoclonal Antibody Therapy Before Surgery for the Treatment of Patients With Breast Cancer

for
Anatomic Stage I Breast Cancer AJCC v8,
Location: Seattle WA
Sponsor: University of Washington

Sex: All

Age: 18+

Code: NCT04329065

Phase 2, Recruiting

Beamion BCGC-1: A Study to Find a Suitable Dose of Zongertinib Used Alone and in Combination With Other Treatments to Test Whether it Helps People With Different Types of HER2+ Cancer That Has Spread

for
Metastatic Breast Cancer, Metastatic Gastric Adenocarcinoma,
Location: Seattle WA, Los Angeles CA, Cerritos CA, Orange CA,
Sponsor: Boehringer Ingelheim

Sex: All

Age: 18+

Code: NCT06324357

Phase 1, Phase 2, Recruiting

A Study of Neladalkib (NVL-655) in Patients With Advanced NSCLC and Other Solid Tumors Harboring ALK Rearrangement or Activating ALK Mutation (ALKOVE-1)

for
Locally Advanced Solid Tumor, Metastatic Solid Tumor
Location: Seattle WA, Vancouver, Edmonton, Sacramento CA,
Sponsor: Nuvalent Inc.

Sex: All

Age: 12+

Code: NCT05384626

Phase 1, Phase 2, Recruiting

SUPRAME-ACTengine® IMA203 vs. Investigator's Choice of Treatment in Previously Treated, Unresectable or Metastatic Cutaneous Melanoma

for
Melanoma, Cutaneous Malignant, Mucosal Melanoma
Location: Seattle WA, Vancouver, Portland OR, Edmonton,
Sponsor: Immatics US, Inc.

Sex: All

Age: 18+

Code: NCT06743126

Phase 3, Recruiting

A Study of CLSP-1025 in Adult Patients With Solid Tumors That Harbor the p53 R175H Mutation

for
Advanced Solid Tumor, Unresectable Solid Tumor,
Location: Seattle WA, Sacramento CA, San Francisco CA,
Sponsor: Clasp Therapeutics, Inc.

Sex: All

Age: 18+

Code: NCT06778863

Phase 1, Recruiting

A Study of ART0380 for the Treatment of Advanced or Metastatic Solid Tumors

for
Advanced Cancer, Metastatic Cancer, Ovarian Cancer,
Location: Seattle WA, Portland OR, Santa Rosa CA, Los Angeles CA,
Sponsor: Artios Pharma Ltd

Sex: All

Age: 18+

Code: NCT04657068

Phase 1, Phase 2, Recruiting

A Study of Tacrolimus/Methotrexate/Ruxolitinib Versus Post-Transplant Cyclophosphamide/Tacrolimus/Mycophenolate Mofetil in Non-Myeloablative/Reduced Intensity Conditioning Allogeneic Peripheral Blood Stem Cell Transplantation (BMT CTN 2203)

for
Graft-versus-host Disease (GVHD)
Location: Seattle WA, Portland OR, San Francisco CA, Palo Alto CA,
Sponsor: Incyte Corporation

Sex: All

Age: 18+

Code: NCT06615050

Phase 3, Recruiting

A Study of 177Lu-FAP-2286 in Advanced Solid Tumors

for
Solid Tumor
Location: Seattle WA, Portland OR, San Francisco CA,
Sponsor: Novartis Pharmaceuticals

Sex: All

Age: 18+

Code: NCT04939610

Phase 1, Phase 2, Recruiting

Donor Stem Cell Transplant With Treosulfan, Fludarabine, and Thiotepa in Treating Patients With Non-malignant Disorders

for
Non-Neoplastic Hematopoietic and Lymphoid Cell Disorder
Location: Seattle WA
Sponsor: Fred Hutchinson Cancer Center

Sex: All

Age: 0 - 50

Code: NCT03980769

Phase 2, Recruiting

Genetically Engineered Cells (FH-FOLR1 ST CAR T Cells) for the Treatment of Advanced Refractory or Recurrent/Progressive Osteosarcoma, FIERCe Trial

for
Advanced Osteosarcoma, Recurrent Osteosarcoma,
Location: Seattle WA
Sponsor: Fred Hutchinson Cancer Center

Sex: All

Age: 1 - 70+

Code: NCT07227571

Phase 1, Recruiting

A Study of Zedoresertib (Debio 0123) in Combination With Temozolomide in Adult Participants With Recurrent or Progressive Glioblastoma and of Zedoresertib (Debio 0123) in Combination With Temozolomide and Radiotherapy in Adult Participants With Newly Diagnosed Glioblastoma

for
Glioblastoma IDH (Isocitrate Dehydrogenase) Wildtype,
Location: Seattle WA, Salt Lake City UT, Dallas TX, Chicago IL,
Sponsor: Debiopharm International SA

Sex: All

Age: 18+

Code: NCT05765812

Phase 1, Phase 2, Recruiting